Share this post on:

Name :
LINGO1 antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
LINGO1 Rabbit Polyclonal antibody. Positive WB detected in mouse brain tissue, rat brain tissue. Observed molecular weight by Western-blot: 83 kDa

Tested applications :
ELISA, WB

Species reactivity :
human, mouse, rat; other species not tested.

Alternative names :
LINGO1 antibody; LRRN6A antibody; FLJ14594 antibody; UNQ201 antibody; LERN1 antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of LINGO1 recombinant protein (Accession Number: NM_032808). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: WB: 1:500-1:5000

Background :
LINGO1 represents leucine rich repeat and Ig domain containing 1

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Etokimab manufacturer
Daratumumab web
Phospho-PTEN (Ser380) Antibody: Phospho-PTEN (Ser380) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Phospho-PTEN(S380). It can be used for WB,ICC assays with tag free, in the background of Human.

Share this post on:

Author: Gardos- Channel